CDC Presents Provisional Mortality Data for 2023 in the United States
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 8, 2024 -- In 2023, there was a provisional total of 3,090,582 deaths in the United States, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Farid B. Ahmad, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues examined mortality in the United States using provisional data, based on preliminary death certificate data, for 2023.
The researchers found a provisional total of 3,090,582 deaths in the United States in 2023. The age-adjusted death rate was 884.2 and 632.8 per 100,000 population among males and females, respectively. The overall rate was 6.1 percent lower than in 2022 (750.4 versus 798.8). All age groups had a decrease in the overall rate. In 2023, the overall age-adjusted deaths rates were lowest and highest for non-Hispanic multiracial and non-Hispanic Black or African American persons, respectively (352.1 and 924.3, respectively). Heart disease, cancer, and unintentional injury were the leading causes of death. The number of deaths from COVID-19 was 68.9 percent lower than in 2022 (76,446 versus 245,614).
"Provisional death estimates can give researchers and policymakers an early signal about shifts in mortality trends and provide actionable information sooner than do the final mortality data," the authors write. "These data can guide public health policies and interventions that are intended to reduce mortality."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-09 07:15
Read more
- ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
- Human Cell Atlas Will Be 'Google Maps' for Health Research
- Marijuana Use Has Fallen 'Dramatically' Among U.S. Teens
- American College of Gastroenterology, Oct. 25-30
- Canadian Teen Hospitalized in Critical Condition With Bird Flu
- Judge Declares Wyoming's Abortion Bans Unconstitutional
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions